Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cue Biopharma, Inc.

0.9692
+0.00420.44%
Post-market: 0.96920.00000.00%16:05 EDT
Volume:59.63K
Turnover:58.08K
Market Cap:61.40M
PE:-1.08
High:0.9992
Open:0.9800
Low:0.9600
Close:0.9650
Loading ...

Strength Seen in TG Therapeutics (TGTX): Can Its 10.2% Jump Turn into More Strength?

Zacks
·
17 Mar

Cue Energy Resources First Half 2025 Earnings: EPS: AU$0.006 (vs AU$0.013 in 1H 2024)

Simply Wall St.
·
02 Mar

AGCO to Exhibit New Solutions and AE50 Award Winners at World Ag Expo and National Farm Machinery Show

PR Newswire
·
06 Feb

Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
30 Nov 2024

Cue Biopharma to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare Conference

GlobeNewswire
·
25 Nov 2024

Analysts Are Bullish on These Healthcare Stocks: Hookipa Pharma (HOOK), Cue Biopharma (CUE)

TIPRANKS
·
18 Nov 2024

Cue Biopharma Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.
·
17 Nov 2024

Cue Biopharma’s Nasdaq Compliance Struggle: Risks and Implications for Future Stability

TIPRANKS
·
16 Nov 2024

Cue Biopharma Inc : Jefferies Cuts Target Price to $4 From $6

THOMSON REUTERS
·
15 Nov 2024

Cue Biopharma Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
15 Nov 2024

Jefferies Cuts Price Target on Cue Biopharma to $4 From $6, Maintains Buy Rating

MT Newswires Live
·
15 Nov 2024

Stifel Nicolaus Remains a Buy on Cue Biopharma (CUE)

TIPRANKS
·
15 Nov 2024

Cue Biopharma, Inc. (CUE) Reports Q3 Loss, Tops Revenue Estimates

Zacks
·
15 Nov 2024

Cue Biopharma Q3 2024 GAAP EPS $(0.17) Beats $(0.19) Estimate, Sales $3.336M Beat $1.520M Estimate

Benzinga
·
15 Nov 2024

Cue Biopharma, Inc. Q3 Net Income USD -8.66 Million

THOMSON REUTERS
·
15 Nov 2024

Cue Biopharma, Inc. Q3 Basic EPS USD -0.17

THOMSON REUTERS
·
15 Nov 2024